Advancing the global public health agenda for NAFLD: a consensus statement

JV Lazarus, HE Mark, QM Anstee, JP Arab… - Nature Reviews …, 2022 - nature.com
Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects
approximately one-quarter of the global adult population, causing a substantial burden of ill …

What's in a name? Renaming 'NAFLD'to 'MAFLD'

Y Fouad, I Waked, S Bollipo, A Gomaa… - Liver …, 2020 - Wiley Online Library
In medicine, language matters and the words used to name and describe a disease can
have a profound impact on patients and their families. Over the last two decades, many …

[PDF][PDF] Diagnosis and treatment of alcohol‐associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases

DW Crabb, GY Im, G Szabo, JL Mellinger… - Hepatology, 2020 - Wiley Online Library
Alcohol-associated liver disease (ALD) represents a spectrum of liver injury resulting from
alcohol use, ranging from hepatic steatosis to more advanced forms including alcoholic …

Liver cirrhosis

P Ginès, A Krag, JG Abraldes, E Solà, N Fabrellas… - The Lancet, 2021 - thelancet.com
Cirrhosis is widely prevalent worldwide and can be a consequence of different causes, such
as obesity, non-alcoholic fatty liver disease, high alcohol consumption, hepatitis B or C …

“They look at us like junkies”: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City

B Muncan, SM Walters, J Ezell, DC Ompad - Harm reduction journal, 2020 - Springer
Background People who inject drugs (PWID) are a medically and socially vulnerable
population with a high incidence of overdose, mental illness, and infections like HIV and …

Redefining fatty liver disease: an international patient perspective

G Shiha, M Korenjak, W Eskridge… - The lancet …, 2021 - thelancet.com
Despite its increased recognition as a major health threat, fatty liver disease associated with
metabolic dysfunction remains largely underdiagnosed and undertreated. An international …

The stigma of alcohol-related liver disease and its impact on healthcare

G Schomerus, A Leonhard, J Manthey, J Morris… - Journal of …, 2022 - Elsevier
People with alcohol-related liver disease (ALD) experience stigma and discrimination. This
review summarises the evidence on stigma in healthcare and its implications for people with …

Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa

G Shiha, K Alswat, M Al Khatry, AI Sharara… - The lancet …, 2021 - thelancet.com
With the increasing prevalence of obesity and type 2 diabetes, fatty liver disease associated
with metabolic dysfunction is a global health problem, especially because it is one of the …

Alcoholic liver disease

HK Seitz, R Bataller, H Cortez-Pinto, B Gao… - Nature reviews Disease …, 2018 - nature.com
Alcoholic liver disease (ALD) is the most prevalent type of chronic liver disease worldwide.
ALD can progress from alcoholic fatty liver (AFL) to alcoholic steatohepatitis (ASH), which is …

[PDF][PDF] Changes in hepatic venous pressure gradient predict hepatic decompensation in patients who achieved sustained virologic response to interferon‐free therapy

M Mandorfer, K Kozbial, P Schwabl, D Chromy… - …, 2020 - Wiley Online Library
Background and Aims Sustained virologic response (SVR) to interferon (IFN)‐free therapies
ameliorates portal hypertension (PH); however, it remains unclear whether a decrease in …